Literature DB >> 26813453

Update on the treatment of androgenetic alopecia.

S Rinaldi1, M Bussa, A Mascaro.   

Abstract

OBJECTIVE: Androgenetic alopecia is the most common type of hair loss, affecting women (50% of menopausal women and a large number of women of childbearing age) as well as males (over 70% of adult men). Since the condition is of an evolutionary nature, it is important to intervene early in order to prevent the progression of the clinical picture. It is equally important to identify all the factors that may hinder the effectiveness of the therapy.
MATERIALS AND METHODS: A literature search was conducted using, as electronic bibliographic database, Medline and the Cochrane library from 1995 until present.
RESULTS: Patients who make use of certain supplements can be less responsive to medical treatments.
CONCLUSIONS: The therapeutic approach to the patient with androgenetic alopecia should be global as the effectiveness of valid therapies may be affected by the patient overlooking the information received from the specialist.

Entities:  

Mesh:

Year:  2016        PMID: 26813453

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  4 in total

1.  A Cross-sectional Study of Plasma Trace Elements and Vitamins Content in Androgenetic Alopecia in Men.

Authors:  Irina N Kondrakhina; Dmitry A Verbenko; Alexander M Zatevalov; Eugenia R Gatiatulina; Alexander A Nikonorov; Dmitry G Deryabin; Alexey A Kubanov
Journal:  Biol Trace Elem Res       Date:  2020-11-05       Impact factor: 3.738

2.  Tetrahydroxystilbene Glucoside Effectively Prevents Apoptosis Induced Hair Loss.

Authors:  Lulu Chen; Huichuan Duan; Feng Xie; Zhen Gao; Xiaoli Wu; Fanfan Chen; Wei Wu
Journal:  Biomed Res Int       Date:  2018-04-02       Impact factor: 3.411

3.  Overexpression of Nanog in amniotic fluid-derived mesenchymal stem cells accelerates dermal papilla cell activity and promotes hair follicle regeneration.

Authors:  Junghyun Park; Eun Kyoung Jun; Daryeon Son; Wonjun Hong; Jihoon Jang; Wonjin Yun; Byung Sun Yoon; Gwonhwa Song; In Yong Kim; Seungkwon You
Journal:  Exp Mol Med       Date:  2019-07-04       Impact factor: 8.718

4.  Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial.

Authors:  B M Piraccini; U Blume-Peytavi; F Scarci; J M Jansat; M Falqués; R Otero; M L Tamarit; J Galván; V Tebbs; E Massana
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-10-25       Impact factor: 9.228

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.